A new screening protocol can detect aggressive prostate cancers more selectively
Prostate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe.
Apr 10, 2024
0
2
Prostate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe.
Apr 10, 2024
0
2
The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate cancer screening, says ...
Apr 9, 2024
0
4
The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of ...
Apr 6, 2024
0
122
A simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.
Apr 5, 2024
0
0
A new study from experts at the University of Exeter has found that a widely used test for prostate cancer may leave Black men at increased risk of overdiagnosis.
Feb 29, 2024
0
2
The UK Prescribing Safety Assessment (PSA) is a medical exam with strong stakeholder support and is associated with increased confidence in prescribing and decreased reporting of medication-related patient harm. The PSA is ...
Nov 10, 2023
1
0
Black men in the United States are more likely to develop prostate cancer than white men, and after diagnosis, they're more likely to have advanced disease and to die than white men with the disease.
Nov 6, 2023
0
0
Research led by the Dana Farber Cancer Institute, Massachusetts, performed a secondary analysis of the Dana-Farber Cancer Institute 05-043 trial. In the paper, "Risk of Short-Term Prostate-Specific Antigen Recurrence and ...
A Purdue University mechanical engineer and his international collaborators have developed a patent-pending method and algorithm to predict the recurrence of prostate cancer in patients treated by radiation therapy.
Oct 9, 2023
0
5
Alberta men with elevated prostate-specific antigen (PSA) levels can now take a new blood test to determine their risk for clinically significant prostate cancer and potentially avoid an unnecessary biopsy.
Oct 6, 2023
0
30